BlackRock Investment Management, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 31 filers reported holding CYTOSORBENTS CORP in Q2 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2016$21,000
-12.5%
3,7760.0%0.00%
Q3 2016$24,000
+41.2%
3,7760.0%0.00%
Q2 2016$17,000
+70.0%
3,776
+45.7%
0.00%
Q1 2016$10,000
-28.6%
2,5910.0%0.00%
Q4 2015$14,000
-6.7%
2,591
+7.4%
0.00%
Q3 2015$15,0000.0%2,4130.0%0.00%
Q2 2015$15,0002,4130.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Skylands Capital, LLC 1,772,000$13,379,0001.58%
Sargent Investment Group, LLC 856,315$6,465,0001.53%
Avenir Corp 1,366,549$10,317,0000.82%
CM Management, LLC 150,000$1,133,0000.82%
Winning Points Advisors, LLC 136,900$1,035,0000.78%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,397,0000.46%
SECTORAL ASSET MANAGEMENT INC 244,660$1,847,0000.15%
Redmile Group, LLC 1,304,369$9,848,0000.15%
Granahan Investment Management 1,003,546$7,577,0000.14%
ACT CAPITAL MANAGEMENT, LLC 35,000$265,0000.14%
View complete list of CYTOSORBENTS CORP shareholders